CARY, N.C., Aug. 25, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical...
Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an...
– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan –...
Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of...
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026Company plans FDA discussion in Q3 2026...
Current Clinical Trial Focus is MSS Colorectal Cancer, Ovarian Clear-Cell Carcinoma, and Soft-Tissue SarcomaDENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) --...
$52M Series A raised in 2024, led by Eight Roads and 3E BioventuresSAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) --...
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics,...
From ‘Right to Try' to Cannabis: Trump's Next Breakthrough Could Unlock FDA Trials."President Trump's marijuana decision must go beyond politics-patients...
Following a landmark court ruling against the Department Of Labor, Duane Boise, CEO of MMJ International Holdings exposes the DEA's...
DELRAY BEACH, Fla., Aug. 22, 2025 /PRNewswire/ -- The global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood...
Bio-Thera and STADA agree to extend their biosimilars alliance to cover tocilizumab, a targeted immunomodulatory monoclonal antibody directed against the...
TORONTO, ON / ACCESS Newswire / August 22, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that...
New Taipei City, Taiwan, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a...
SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design...
SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to...
In this free webinar, learn how data-driven services can address the challenges that contributing factors raise in clinical trial design,...
AUSTIN, Texas, Aug. 21, 2025 /PRNewswire/ -- SubjectWell, the Patient Experience Platform driving predictable clinical trial enrollment and patient retention,...
NEW CASTLE, Del., Aug. 21, 2025 /PRNewswire/ -- IgniteData, a leader in intelligent clinical trial data automation, is proud to announce...
Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY /...